| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |